NephroGenex Inc (NASDAQ:NRX)

4.36
Delayed Data
As of Jul 27
 -0.12 / -2.68%
Today’s Change
3.96
Today|||52-Week Range
17.98
-67.34%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close4.48
Today’s open4.57
Day’s range-- - --
Volume28,833
Average volume (3 months)59,868
Market cap$46.4M
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)+89.09%
Earnings growth (this year)-2.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...-0.46-0.55%
CBAYCymaBay Therapeutics...+0.14+4.98%
MCPIMed Cannabis Pharma ...-0.05-12.50%
BIOSBioScrip Inc-0.01-0.39%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$16.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pierre Legault
President &
Chief Scientific Officer
J. Wesley Fox Ahmann
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers